JAMA Network: Remote Symptom Monitoring With Electronic Patient-Reported Outcomes in Clinical Cancer Populations
In this nonrandomized controlled trial, hospitalizations were 19% and 13% lower among patients receiving RSM at 3 and 6 months, respectively. This nonrandomized controlled trial found that RSM implementation was associated with reduced risk of hospitalizations for patients with cancer, supporting the need to expand implementation nationally.
Loading...
Reload document 
Open in new tab